BRENDA WITSAMAN: Open Payments
NPI 1811492424 · MEDINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 15 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $176 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $85 |
| AstraZeneca Pharmaceuticals LP | 2 | $56 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Blueprint Medicines Corporation | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $21 |
| Aveo Pharmaceuticals, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: KEYTRUDA, INJECTAFER, AYVAKIT, SCEMBLIX, LIBTAYO, JEMPERLI, ERLEADA, FOTIVDA.
Industry payments across OH — which companies pay providers there.
